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The use of large pedigrees is an effective design for identifying rare functional variants affecting heritable traits. Cost-effective studies
using sequence data can be achieved via pedigree-based genotype imputation in which some subjects are sequenced and missing geno-
types are inferred on the remaining subjects. Because of high cost, it is important to carefully prioritize subjects for sequencing. Here, we
introduce a statistical framework that enables systematic comparison among subject-selection choices for sequencing. We introduce a
metric ‘‘local coverage,’’ which allows the use of inferred inheritance vectors to measure genotype-imputation ability specifically in a
region of interest, such as one with prior evidence of linkage. In the absence of linkage information, we can instead use a ‘‘genome-
wide coverage’’ metric computed with the pedigree structure. These metrics enable the development of a method that identifies efficient
selection choices for sequencing. As implemented in GIGI-Pick, this method also flexibly allows initial manual selection of subjects and
optimizes selections within the constraint that only some subjects might be available for sequencing. In the present study, we used sim-
ulations to compare GIGI-Pick with PRIMUS, ExomePicks, and common ad hoc methods of selecting subjects. In genotype imputation
of both common and rare alleles, GIGI-Pick substantially outperformed all other methods considered and had the added advantage of
incorporating prior linkage information. We also used a real pedigree to demonstrate the utility of our approach in identifying causal
mutations. Our work enables prioritization of subjects for sequencing to facilitate dissection of the genetic basis of heritable traits.Introduction
A major goal in human genetics is the identification of
genetic variants responsible for heritable diseases. Study
designs based on pedigrees in which heritable diseases
segregate have successfully led to the identification of
over 4,500 relevant genes.1 Although genome-wide associ-
ation studies (GWASs) based primarily on unrelated sub-
jects have also become a widely used design in the search
for common risk alleles,2 the hypothesis that many herita-
ble diseases are influenced by rare risk alleles continues to
support the use of pedigrees as one efficient design for
identifying risk alleles.3,4 As part of the process of risk-allele
identification, the use of sequence data enables direct
evaluation of variants, possibly within candidate regions
already identified by linkage analysis.5–16 However,
sequencing large numbers of subjects is difficult for multi-
ple reasons, including high cost and the need for relatively
large amounts of high-quality DNA. A cost-effective way to
obtain genotypes on subjects who are not sequenced is to
infer missing genotypes via imputation17–19 by combining
existing sparse genotypes available on many subjects with
sequence data collected on only some subjects in pedi-
grees. Pedigree-based imputation is particularly effective
for rarer, segregating variants18 (and unpublished data).
Determining which subjects to sequence is an important
design decision. Because it could be infeasible or imprac-
tical to sequence all available subjects in a pedigree, this
constraint requires prioritization of a subset of subjects
for sequencing. These subjects can be selected all at one
time, or an initial small group of subjects can be selected1Division of Medical Genetics, Department of Medicine, University of Washi
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The Americfor sequencing and any additional subjects can be selected
depending on the results from the initial sample. When
only a few subjects can be sequenced, the choice of subject
selection in either case is particularly critical. All of these
possibilities create challenges for the design of sequencing
studies in pedigrees and suggest the need for a flexible and
adaptive approach to subject selection.
It is worthwhile to consider two important issues. First,
subject selection should benefit subsequent genotype
imputation. Additional subjects with imputed genotypes
can form an integral part of downstream analyses and
have the potential to increase the statistical power to
detect causal variants19,20 (and unpublished data). Second,
subject selection should benefit from the incorporation of
prior knowledge of candidate regions when such informa-
tion is available from, e.g., linkage analyses or GWASs.21
This information allows us to prioritize subjects to opti-
mize genotype imputation in these regions.
Decisions related to subject selection should incorporate
relevant information in a systematic and quantitative
manner. A suitable metric is necessary for quantification
of the relative values of different sequencing choices. In
addition, an automated tool that systemically selects
subjects would be useful. In the absence of such a tool,
investigators need to use ad hoc methods to choose
subjects for sequencing. Furthermore, selecting subjects
manually for multiple pedigrees is tedious, so methods
that facilitate automated and efficient prioritization of
subjects would be helpful.
Existing tools that automate selection of subjects for
sequencing are limited. PRIMUS is a program that selectsngton, Seattle, WA 98195, USA; 2Department of Biostatistics, University of
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Figure 1. Sequencing Choices Affect the Percentage of Alleles
Called
Founder chromosomes and copies of those same founder chromo-
somes in descendants are labeled with numbers, and alleles of
genotypes are labeled with letters. Observed alleles are in bold
black, and imputed alleles are in nonbold blue. Vertical lines repre-
sent alleles that can be phased unambiguously to FGLs. Subjects
who were selected for sequencing are indicated by shading. Three
subject-selection choices are presented: (A) parent and child are
selected, and the child is homozygous for the marker, (B) founder
spouses are selected, and both are heterozygous for the marker,
and (C) parent and child are selected, and both are heterozygous
for the marker.subjects for sequencing.22 However, because PRIMUS aims
to identify a set of maximally unrelated subjects, this
approach might not be ideal for subject selection in
pedigrees. ExomePicks is another program that selects
subjects for sequencing (see Web Resources). Its approach
is based on selecting units of related subjects from the old-
est to youngest generations, which is logical because this
encourages determination of haplotypes across loci. How-
ever, this algorithm does not leverage information about
the descent of chromosomes in a local region of interest,
nor does the program incorporate existing information
about subjects who might have already been sequenced.
Here, we introduce a general subject-selection frame-
work that facilitates the evaluation and comparison of
subject-selection choices in sequencing studies. We also
introduce ‘‘coverage’’ as one metric to naturally relate
pedigree-based genotype imputation to subject selection.
This metric enables the use of inferred inheritance vectors
(IVs)23 to optimize imputation of alleles in candidate re-
gions when such information is available. Our approach
can incorporate information about IVs to guide subject
selection for sequencing. If a candidate region is not avail-
able, a variant of this metric can be used for optimizing
selection genome-wide. This approach also provides
options for manual selection of some subjects before
deciding on the remaining subjects to sequence, and it
optimizes choices (within realistic constraints) only
among subjects who are available for sequencing. In our
study, we used simulation to compare our approach with
existing methods and used a real-pedigree example to
demonstrate the utility of our approach. We implemented
our approach in the program GIGI-Pick.Subjects and Methods
Overview
We describe here the primary scenario that motivates our work.
Linkage analysis might have already identified a candidate region
that potentially contains a risk allele in a gene influencing the
phenotype. For identifying the risk allele(s), sequence data are
collected for directly evaluating variants in a candidate region. A
limited budget is available for sequencing a maximum number
of subjects. Therefore, the plan is to select a few subjects for
sequencing and then impute missing genotypes for further evalu-
ation to reduce the need for follow-up genotyping. For brevity,
here we refer to the selection of subjects for sequencing as ‘‘subject
selection.’’
Our framework focuses on genotype imputation. In pedigrees,
genotypes are imputed with information from either inferred
inheritance or external population data, such as population allele
frequencies.18 When information from inheritance is used, alleles
are imputed with very high accuracy, even for rare alleles, and are
referred to as ‘‘practically’’ determined18 (and unpublished data).
Using imputed genotypes, we can then perform desired down-
stream analyses, ranging from exploratory analyses to formal
statistical tests, such as family-based association tests of variants,
including those for single variants24–26 or regional associa-
tions.20,27258 The American Journal of Human Genetics 94, 257–267, FebruaryStatistical Framework
Inheritance Vectors
Our framework for subject selection capitalizes on the concept of
IVs. IVs23 represent the descent of chromosomes in a pedigree at
specified positions. Using IVs, we can also represent independent
founder chromosomes with founder genome labels (FGLs)28
(Figure S1, available online). Each subject has a pair of FGLs
because he or she has two copies of chromosomes originally
descended from founder chromosomes. Identity-by-descent
(IBD) graphs partition FGLs into distinct components.29,30 In an
IBD graph, the nodes are the FGLs and the edges are the subjects
who are sequenced and observed for the genotypes at the locus
of interest. By connecting FGLs to observed subjects who have
these FGLs, we can construct one or multiple disjoint IBD graphs
(Figure S1). Because of meiotic recombination, IBD graphs can be
different at different positions on the chromosome.
The program gl_auto31 from the MORGAN v.3 software package
uses genotypes of relatively sparse markers, marker map positions,
pedigree structure, and population allele frequencies to sample IVs
that are consistent with the observed data. Here, we define these
sparse markers as framework markers, which can be markers
from linkage panels that consist of short tandem repeats (STRs)
or sparse SNPs. Similar to many pedigree-based linkage-analysis
methods,29,32 gl_auto uses the Lander-Green framework23 for
small pedigrees. To handle large pedigrees, gl_auto uses a hybrid
Markov-chain Monte-Carlo (MCMC) sampler33,34 that is based
on both the Elston-Stewart35 and the Lander-Green algorithms.
Connection between Genotype Imputation and Subject Selection
In pedigrees, subject selection can affect genotype imputation. For
illustration, we assume that the IV at a position of interest in the
sequence data is known. If all observed alleles at that position
can be unambiguously assigned to FGLs at some point in the
pedigree, alleles from all unobserved subjects who share copies
of these FGLs can be imputed (Figure 1A). We refer to the ability6, 2014
to unambiguously assign marker alleles to FGLs as the ability to
phase the observed genotypes with respect to the FGLs, or for
brevity, the ability to phase the observed genotypes. If the
observed genotypes cannot be phased, alleles from subjects who
share copies of these FGLs cannot be imputed (Figure 1B), except
from subjects who share the same pair of FGLs with observed
subjects (Figure 1C). Thus, the choice of subject selection affects
the percentage of alleles called, defined as the percentage of alleles
that are either observed or imputed with the IV in pedigree-based
genotype imputation.
Metric: Coverage
We introduce coverage as a metric to compare subject-selection
choices. At this point, we continue to assume that the IV at a
locus on the chromosome is known, but we will relax this
assumption later. Conditional on a fixed IV for a particular choice
of subject selection, coverage is the expected percentage of the
copies of alleles called for a variant at a random locus. Because
genotypes are not observed before sequencing, coverage is an
expected value integrated over all potential genotype configura-
tions in subjects intended for sequencing for the particular
subject-selection choice. This expectation accounts for the prob-
ability of phasing genotypes, given that the probability of
phasing affects the number of alleles that can be called. If no
subjects are sequenced, the coverage is 0. If all subjects are
sequenced or if all alleles from subjects who are not sequenced
can be imputed, the coverage is 1.
Coverage is easily computed. The calculation first translates the
known IV into I disjoint IBD graphs,28,30 as denoted by ibdgi,
where i ¼ 1, 2, ., I (Figure S1). N is defined as the number of
subjects in the pedigree, so 2N is the total number of alleles in
the pedigree at a locus and is the denominator for the computa-
tion of coverage. In each ibdgi, there is a probability, pi, that the
observed genotypes can be phased and a remaining probability,
qi ¼ 1  pi, that the observed genotypes cannot be phased. If the
observed genotypes can be phased, a total of Fi alleles in the pedi-
gree can be called. If the observed genotypes cannot be phased, a
total of Gi alleles can be called, where 0%Gi% Fi. Then, the calcu-
lation combines the number of alleles expected to be called from
all ibdgi partitions. Thus, coverage is expressed as
coverage ¼
X
Fi pi þ Gi qi

2N: (Equation 1)
The terms Fi andGi in Equation 1 are easily calculated. Each term
has two components: (1) Fi ¼ wi þ xi, where wi is the number of
copies of alleles that are directly genotyped and xi is the number
of copies of alleles that can additionally be imputed because we
can infer alleles in unobserved subjects who share FGLs with
some observed subjects from ibdgi; and (2) Gi ¼ wi þ yi, where wi
is defined above and yi is twice the number of unobserved subjects
who have both alleles identical by descent with those of some
observed subjects from ibdgi (see Figure 1C).
It is also simple to calculate qi in Equation 1. The probability qi is
equal to the probability that alleles from ibdgi display a pattern of
alternating allelic types for two alleles, because such genotype con-
figurations are the only configurations for which the genotypes
cannot be phased in ibdgi. For instance, if an ibdgi is a linear graph,
i.e., 1-3-5, then qi ¼ PAPaPA þ PaPAPa ¼ PAPa (where Pa is the pop-
ulation minor allele frequency [MAF] and PA ¼ 1  Pa) for diallelic
variants, which include the majority of SNPs or sequence variants.
Estimating Coverage
Although coverage is a conceptual quantity defined for an arbi-
trary known IV, we need to estimate coverage for practical useThe Americwithout having the known IV. Here, we extend the concept of
coverage. First, we define local coverage as the estimated coverage
in a region of interest. The use of local coverage can optimize
genotype imputation in a specific chromosomal region and is ideal
for targeting subject selection in a region with positive evidence of
linkage. We sample a set of n IVs at the beginning and end points
of the region of interest as previously described.18,36 To reduce the
amount of computation and to select representative MCMC-based
samples, we alternatively select IVs between the beginning and
end points of the region of interest so that coverage is computed
on a total of n instead of 2n IVs. (Although in our evaluation
here we only sampled IVs at the beginning and end points of a
region, our implementation allows selecting sampled IVs at multi-
ple points, which could be desired for use in a large candidate
region of interest.) After sampling IVs, we calculate coverage on
each sampled IV. Finally, we take the average of the coverages
to get the final estimate of the expected coverage. Second, we
propose genome-wide coverage as a local-coverage variant estimated
from the expected coverage at a random locus in the genome. This
metric is useful if prior information about a candidate chromo-
somal region is not available or if multiple trait phenotypes are
collected on the pedigree, so identifying rare variants related to
many different genomic regions might be of interest. In this
case, it might not be obvious which subjects or region to focus
on. Genome-wide coverage is estimated by calculation of the
average coverage across a large set of randomly sampled IVs
compatible with the pedigree structure. To randomly sample an
IV at a locus while conditioning on the pedigree structure, the
method simulates each meiotic event corresponding to the trans-
mission of a chromosome from a nonfounder’s parent to the
nonfounder with an equal chance of maternal or paternal trans-
mission. For example, to sample a random IV in the pedigree of
Figure 1, the method simulates a total of ten meiotic events
belonging to the three siblings in the second generation and the
two siblings in the third generation, in which each meiotic event
has a 50% chance of inheriting the maternal chromosome and a
50% chance of inheriting the paternal chromosome. Thus, a
collection of these randomly simulated IVs (generated by condi-
tioning on the pedigree structure) is used for estimating coverage
at a random locus in the genome.
Joint-Prioritized Selection Algorithm
Using estimated coverage, we use a ‘‘joint-prioritized’’ algorithm
for sequential selection of subjects. This method aims to select m
subjects from n subjects available for sequencing (Figure 2). First,
the algorithm selects the first subject by iterating through the
entire list of subjects available for sequencing and computes the
estimated coverage on each subject. The desired estimated
coverage, which is either the local or the genome-wide coverage,
is calculated with the method described above. Second, the
method ranks the estimated coverages among the choices, retains
the ranked top g choices with the highest estimated coverages,
and discards all other choices. These top choices are called
templates for the next step. Third, the algorithm selects a second
subject by using each template one by one in turn. For each
template, the algorithm loops through the subjects not in the
template, temporarily adds an unselected subject to the template,
and calculates the estimated coverage on each temporary selec-
tion. Thus, with g templates and n  1 unselected subjects avail-
able for sequencing, a total of g (n  1) estimated coverage scores
are calculated. Fourth, the algorithm retains g unique combina-
tions of selected subjects with the highest estimated coverage






















Figure 2. Joint-Prioritized Subject-Selection Method
In this example, the number of templates to keep (g) is 2. In the
first selection, the method computes coverage for each subject
(a–h). Subject e has the highest coverage, and subject c has the
second-highest coverage, so they are kept as templates. In the
second selection, the method considers adding another subject
to each template, e.g., (e, a), (e, b), (e, c), (e, d), (e, f), (e, g),
(e, h), (c, a), (c, b), (c, d), (c, f), (c, g), and (c, h). Set (e, g) gives
the highest coverage, and set (e, h) gives the second-highest
coverage, so they are kept as templates for the third selection.
This scheme repeats until the desired number of subjects is
selected. After the third step, sets (e, g, d) and (e, h, d) give the
highest and second-highest coverages, respectively. If a total of
three subjects are desired, set (e, g, d) becomes the final selection.now become the new templates for the next step. The fifth step
repeats steps 1–4 but replaces n  1 unselected subjects with
n  x, where x is the number of subjects already selected at the
beginning of each step, until m subjects are selected. After m
subjects are selected, the top template becomes the final subject-
selection choice.
The joint-prioritized subject-selection algorithm has a few
features. First, this algorithm is a forward-selection extension
that allows exploration of more selection choices. When g ¼ 1,
this algorithm reduces to forward selection, and when g > 1, the
algorithm has a higher chance of finding a better choice after
multiple selection steps. Second, unlike forward selection, the
joint-prioritized selection algorithm does not make permanent
selection after each step but instead continues to refine selection
choices on the basis of current templates to maintain flexibility.
Third, the algorithm considers multiple first choices so that
different starting choices can be explored. Fourth, the algorithm
keeps computation costs low by focusing only on templates with
high potential for an improved selection outcome, under the
assumption that only top templates are likely to be high quality.
Fifth, this algorithm enables efficient computation, given that
the number of calculations is only g times more than forward
selection, where g is much smaller than n.
In computing the estimated coverage, Pa is assumed to be a fixed
value and is treated as a tuning parameter. Because there are
multiple variants in a chromosomal region, the use of coverage
must assume one fixed value of Pa. To avoid confusion between
the fixed value of Pa used for computing coverage and the popula-
tionMAFs of different variants in a chromosome, we denote Pa as a
when it is used as the fixed value tuning parameter for computing260 The American Journal of Human Genetics 94, 257–267, Februarycoverage. When a is high (e.g., a ¼ 0.5), the probability of expect-
ing heterozygous genotypes is also high, so the predicted probabil-
ity of phasing alleles in the IBD graph would be lower than if a
were low.
A high value of a is used for optimizing genotype imputation of
rare alleles. A low value of a assumes that most founder alleles of a
marker have copies of the common allele, so most genotypes are
expected to be trivially phased because they would be homo-
zygous for the common alleles. When genotypes are expected to
be trivially phased with high probability, the method achieves
maximizing coverage by selecting subjects who provide indepen-
dent unobserved FGLs instead of selecting subjects who are
more closely related to encourage phasing of existing observed
genotypes. Thus, to instead encourage phasing of genotypes that
contain rare alleles, the method needs to use a high value of a. Un-
less otherwise specified, the default value of a is 0.5.
Evaluation
Implementation in GIGI-Pick
We implemented our approach in the program GIGI-Pick. This
program provides both batch and interactive modes that allow
users to easily explore and compare selection choices. To compute
genome-wide coverage, the program only requires a pedigree file,
whereas to compute local coverage, the program further requires
IVs at the positions of framework markers. These IVs can be ob-
tained via the program gl_auto.31
Simulated Data
To evaluate and compare results from GIGI-Pick with those from
alternative approaches, we simulated data on a 52-member five-
generation pedigree also used in previous studies18,37 (Figure S2).
To resemble a realistic scenario in which subjects in the upper
generations would typically be deceased, we defined only the 46
subjects from the lowest three generations as available for
sequencing. Because of the size of this pedigree, it was computa-
tionally infeasible to evaluate all sequencing choices. For instance,
there are over 53 million combinations of selecting seven subjects
among 46 available subjects.
On a 100 cM chromosome, we simulated three types of markers.
First, we simulated diallelic framework markers to infer IVs. These
markers were simulated in a previous study at a density of one
marker per 0.5 cM and had a MAF of 0.5.18 We retained genotypes
of framework markers on 36 subjects (Figure S2) to resemble a
common scenario that genotypes from an existing panel of
genome-scan markers are available on most subjects. Second, we
simulated dense SNPs to specifically evaluate the performance of
imputing genotypes across the full range of possible allele fre-
quencies. Within the 48–52 cM region of the chromosome, we
used a total of 1,000 simulated SNPs at a density of one marker
per 0.004 cM and MAF uniformly distributed between 0 and
0.5.18 Third, we simulated 5,000 rare variants in the same 4 cM
region of the chromosome to evaluate the performance of
imputing rare alleles, which might be more likely to represent
the variants of interest in sequence data. For each rare variant,
we selected a single random FGL to contain the rare allele. For
all types of markers, we simulated alleles in founders and propa-
gated founder alleles through the pedigree by using previously
simulated descent patterns18,37 to create the original marker data
sets. This implies that multiple subjects who have copies of the
randomly selected FGL with the rare variant contain copies of
the rare allele. To ensure consistency in our interpretations, we
repeated the simulation for a total of ten independent data sets
with different patterns of chromosomal descent. The variability6, 2014
of the results among data sets was low, so these data sets were suf-
ficient for our purpose (see Results).
Comparing Subject-Selection Choices in Simulated Data
We compared selected subjects obtained with GIGI-Pick to those
obtained with five other methods of subject selection (Figures S3
and S4). The first category of methods selects subjects via
automated programs GIGI-Pick, PRIMUS, and ExomePicks. Details
on program use are given further below. We obtained results from
GIGI-Pick by using either local (GIGI (local)) or genome-wide
(GIGI (GW)) coverage. We obtained results from PRIMUS22 with
an option to select a set of maximally unrelated subjects. This
addresses the efficacy of maximizing the number of ascertained
independent chromosomes for pedigree-based genotype imputa-
tion. We also obtained results from ExomePicks. The second
category of methods chooses subjects manually via defined selec-
tion schemes. Inspired by designs in which distantly related
affected subjects from the bottom generations are selected,6,38
the ‘‘bottom-only’’ scheme selects affected subjects from the
lowest generation of the pedigree. The ‘‘bottom and parents’’
scheme is a variant of the ‘‘bottom-only’’ scheme and replaces
some bottom subjects with their parents (descended from the
central branch of the pedigree) to facilitate phasing. The final
category of selection method selects subjects randomly. We per-
formed this random selection a total of 200 times to characterize
the spectrum of imputation performance and to create a bench-
mark for comparison.
For each selectionmethod, the experiment followed three steps.
First, we used the method to select subjects for genotyping.
Second, we retained genotypes on the chosen subjects. Third, we
performed pedigree-based genotype imputation by using GIGI
v.1.02, which is a program that can handle genotype imputation
in large pedigrees.18
We performed three evaluations. First, we compared imputation
performance (described below) among various selection methods
and among random subject selections for five, seven, or ten
selected subjects. Second, we computed the correlation between
the estimated coverage and the actual imputation performance
to evaluate the usefulness of estimated coverage for predicting
imputation performance. Third, we varied the values of a (0.01,
0.1, 0.3, and 0.5) for GIGI-Pick (local) to evaluate how changing
the values of the tuning parameter affects subject selection
(Figure S5).
Given different choices for selecting subjects, we used different
performance measures to evaluate genotype imputation for SNPs
and rare variants. For SNPs, we computed accuracy, defined as the
percentage of genotypes correctly called with the most likely
genotype configuration, and averaged it over all SNPs. The reason
for calling the most likely genotypes was to ensure that all alleles
were called in every subject-selection choice in order to establish
a common basis for comparison. For rare variants, computing the
genotype accuracy on the basis of the most likely genotype
configuration was less relevant because we were mainly inter-
ested in determining which subjects had the rare alleles and
less interested in the large number of genotypes that were homo-
zygous for the common alleles. Therefore, we computed sensi-
tivity for calling rare alleles as the percentage of rare alleles called
correctly after genotype imputation and averaged it over all var-
iants. We computed sensitivity by using high-confidence calling,
which calls both alleles of a genotype if the estimated probability
of a genotype configuration is over 90% or calls one of the two
alleles if the estimated probability of a specific allele is over
95%.18 For any alleles not called, the common allele was filledThe Americin. We also calculated specificity as the percentage of common
alleles called correctly and averaged it over all variants. Because
the specificity was always high (>99.7%) under all subject-selec-
tion choices, our comparison focused on sensitivity. We called ge-
notypes strictly for the purpose of evaluation. Unless otherwise
specified, all results were further averaged across the ten simu-
lated data sets.
Program-Use Details
GIGI-Pick (local) uses a set of sampled IVs at the positions of
interest. Using a set of framework markers as described in the
text, we inferred IVs at the positions of framework markers via
gl_auto.31 Then, using a previously described method18 imple-
mented in GIGI-Pick, we sampled 1,000 IVs at the bounding
positions 48 and 52 cM. GIGI-Pick (GW) uses a set of sampled
IVs based on the pedigree structure. On the basis of the pedigree
structure, we simulated 500 IVs with random descent patterns.
GIGI-Pick was run for ten selection steps with g ¼ 8. Using the
final ten subject selections, we retained the appropriate number
of subjects as specified in the analysis plan (e.g., seven subjects
selected) according to the order of these subjects selected in
GIGI-Pick.
PRIMUS selected a set of maximally unrelated subjects, and this
set corresponded to a set of founders in the pedigree. Because
PRIMUS does not have an option to ignore certain subjects, it
selected founders who were actually not available for sequencing
from the top two generations. Given that we could not include
subjects from the upper two generations, we instead manually
selected relatives of these upper founders before other subjects
were selected. To be consistent with the PRIMUS scheme for
selecting the maximally unrelated subjects, we first selected the
leftmost child from each of the two branches in the third gen-
eration. We then selected subjects from the top to the bottom
generations among the maximum independent sets determined
by PRIMUS.
In ExomePicks, we selected subjects by using the ‘‘per family’’
output as recommended. Groups of subjects who yielded the
highest expected gain were selected.
Real Data
Weevaluated the use ofGIGI-Pick on a large real pedigree (Figure 3)
in which a causal, dominant disease mutation was previously
discovered.39 This pedigree contains strong evidence of linkage
in a region on chromosome 1,39 thus providing a candidate
region. It also contains 26 affected subjects scattered across three
branches, but the disease has reduced penetrance. Thirty-nine
subjects were typed for the causal variant, and copies of the causal
mutation were observed in 14 subjects. Here, the causal variant
represents a variant that would be detected from sequencing and
is the variant that we would hope to rediscover through statistical
testing using the imputed genotypes and the phenotype of inter-
est. Among the 39 subjects typed for the causal variant, 32 subjects
were also typed for SNP genotypes. These 32 subjects were
assumed to be the subjects available for sequencing. All subjects
or their representatives gave written informed consent, and the
study was approved by the University of Washington Human Sub-
ject Review Board.
Our use of this example resembles a realistic scenario. First, we
manually selected two affected subjects available for sequencing
from two different branches of the pedigree. It is practical to use
information about disease status to first target subjects who poten-
tially have copies of the causal mutation, and selecting two
affected subjects is a common strategy in which some distantly
related affected subjects in the pedigree are sequenced.6,11,16,38,40an Journal of Human Genetics 94, 257–267, February 6, 2014 261
Figure 3. Real Pedigree Used for Subject Selection
Affected subjects are shaded, and subjects available for sequencing
are underlined. Only subjects with some genotype data or descen-
dants with genotype data were included. Some subjects were
omitted from this figure for the protection of confidentiality.



















Figure 4. Sensitivity of Calling Rare Alleles as a Function of the
Number of Subjects Selected
Programs (solid lines) are as follows: (A) GIGI (local), (B) GIGI
(GW), (C) PRIMUS, and (D) ExomePicks. Ad hoc schemes (dashed
lines) are as follows: (E) bottom only and (F) bottom and parents.
Refer to Figures S3 and S4 for the actual subjects selected. The ‘‘bot-
tom and parents’’ and ‘‘bottom-only’’ designs had the same sensi-
tivity in the first six selected subjects because the subjects selected
were the same until the seventh choice.Second, we selected three additional subjects for genotyping by
using GIGI-Pick initially running with a total of 15 selection steps
and g ¼ 8. This corresponds to sequencing a total of fewer than
10% of subjects in this pedigree. To incorporate linkage informa-
tion, we estimated local coverage with inheritance vectors inferred
by the program gl_auto31 by using 31 STRs supplemented with 70
SNPs near the region with evidence of linkage. Third, we used
GIGI18 to impute genotypes at the causal variant and performed
an association test correcting for relatedness25 on the called
imputed genotypes to evaluate whether the subjects selected for
sequencing would provide evidence of association after genotype
imputation. For this purpose, we used the pedigree-based kinship
matrix and a corrected chi-square test24 with a p value derived
from the theoretical distribution of the test statistic. For imputa-
tion, we used a MAF of 0.2 for the variant because it was a more
conservative specification of the MAF than a low MAF and
minimized the chance of false-positive conclusions.41 We also
evaluated a lower allele frequency such as might be used in the
context of strong outside prior information. Fourth, because the
result from this analysis might be sensitive to the original choice
of which of the two initial subjects was manually selected, we
repeated the analysis above on all of the 23 pairs of affected sub-
jects from different branches.Results
Simulations
There was a clear relationship between the number of
subjects selected and the sensitivity in calling rare alleles,
as well as a generally consistent ranking of the selection
methods (Figure 4). Among all subject-selection methods,
GIGI-Pick (local) yielded the highest sensitivity over the
entire range of numbers of subjects selected. GIGI-Pick
(GW) yielded lower sensitivity than did GIGI-Pick (local),
suggesting that incorporating a candidate region identified
by linkage analysis can further improve subject selection
toward the goal of identifying causal variants. However,
GIGI-Pick (GW) still substantially outperformed other
methods. ExomePicks yielded the third-highest sensitivity
at seven or fewer subjects selected, but the ‘‘bottom and
parents’’ design yielded higher sensitivity than did Exome-
Picks at seven or more subjects selected. In this ‘‘bottom262 The American Journal of Human Genetics 94, 257–267, Februaryand parents’’ design, the first six subjects selected were
identical to those in the ‘‘bottom-only’’ design, so the
sensitivity values from the two methods were identical in
this range. However, at seven to ten subjects selected,
typing parents in the ‘‘bottom and parents’’ design led
to higher sensitivity than did typing siblings in the
‘‘bottom-only’’ design. Finally, PRIMUS performed poorly
in comparison to all other subject-selection methods,
and its relative performance decreased with increasing
numbers of selected subjects.
Differences in imputation performance among selection
methods were substantial. Here, we focus the results on
seven subjects selected (Figure 5 and Table 1). GIGI-Pick
(local) yielded the highest sensitivity (58.4%) and was
better than all random choices (100th percentile relative
to the distribution of random selections of subjects).
GIGI-Pick (GW) was the second-best selection method
(54.2% sensitivity; 99.5th percentile) but had 4.2% lower
sensitivity than did GIGI-Pick (local). GIGI-Pick (local)
yielded a markedly 14.4% absolute difference in sensitivity
over the ‘‘bottom and parents’’ design and had a 38.8%
absolute difference in sensitivity in comparison to the least
effective selection method, PRIMUS (19.6% sensitivity;
<1st percentile). For imputing more common SNPs, GIGI-
Pick also yielded better accuracy than did other selection
methods (Table 1), although the absolute differences in
accuracy among methods were less dramatic than those
for the rare variants. Nevertheless, the rank order of impu-
tation performance was the same for rare variants and SNPs
(Table 1). In addition, the qualitative findings above were
similar for five or ten subjects selected (Tables S1 and S2),6, 2014
Figure 5. Sensitivity Computed for Different Selection Methods
against the Distribution from 200 Samples of Random Subject
Selection for Seven Subjects Selected
The histogram describes the distribution of sensitivity values from
samples of random subject selection. Subject-selection methods
are compared against random subject selection, and the locations
of the lines indicate the sensitivity of the methods. Programs are
depicted by solid lines, and ad hoc schemes are represented by
dashed lines.and summaries per data set also suggested similar inter-
pretations (Table S3).
Results from other methods for subject selection also
have interesting features. First, sensitivity varied substan-
tially across random choices (~25% to ~58%) (Figure 5),
which further illustrates that the choice of subject selec-
tion can strongly affect imputation of rare alleles. Second,
PRIMUS had substantially lower sensitivity than did all
other subject-selection methods and was considerably
worse than random selection for subsequent pedigree-
based imputation (19.6%; <1st percentile) (Table 1). Third,
by focusing on selecting subgroups of related subjects,
ExomePicks (41.3%; 39.5th percentile) yielded markedly
higher sensitivity than did PRIMUS. Interestingly, Exome-
Picks was less effective in imputing SNPs (29th percentile)
than in imputing rare variants (39.5th percentile) relative
to random choices, but it still underperformed random
selections (<50th percentile) even for rare variants.
High estimated coverage is a strong indicator of high
genotype-imputation performance. The correlation be-
tween the accuracy and local coverage was strong (e.g.,
0.90 in data set 1), suggesting that coverage is useful for




Sensitivity (%) Percentile (%)b
GIGI-Pick (local) 58.4 100
GIGI-Pick (GW) 54.2 99.5
PRIMUS 19.6 <1
ExomePicks 41.3 39.5
Bottom only 35.0 10.5
Bottom and parents 44.4 65.0
aResults were averaged across all ten simulated data sets. Refer to Figures S3 and
bRelative to 200 random selections of subjects for sequencing.
The Americobservations in which the local-coverage values were
high generally corresponded to high accuracy values.
This result was consistent across data sets (data not
shown). The correlation between sensitivity and local
coverage was weaker (0.72 in data set 1) than the correla-
tion between accuracy and local coverage, but high
coverage values were still correlated with high sensitivity
values (Figure 6). As would be expected, genome-wide
coverage was less indicative of the per-run imputation
performance in the particular region evaluated (correla-
tions of 0.57 for accuracy and 0.46 for sensitivity in data
set 1). However, genome-wide coverage was still highly
predictive of the average imputation performance across
data sets (correlations of 0.88 for accuracy and 0.74 for
sensitivity across data sets; Figure 6). Thus, the selection
of subjects who optimize the estimated coverage is ex-
pected to yield high imputation performance.
The performance was relatively insensitive to the specific
choice of a (Table S4). Among the considered values of a,
GIGI-Pick (local) had the highest sensitivity (58.4%;
100th percentile) and accuracy (81.9%; 100th percentile)
for a ¼ 0.5. As a decreased, both sensitivity and accuracy
decreased. The changes were small for a ¼ 0.3, but sensi-
tivity decreased sharply for a ¼ 0.1, although the accuracy
remained high relative to random selections. For a ¼ 0.01,
both sensitivity and accuracy were low. This was because
GIGI-Pick selected more distantly related subjects or mar-
ried-ins at a low value of a (Figure S5), as was predicted
in the Subjects and Methods.Real Data
The real-pedigree example demonstrates that GIGI-Pick
can provide useful guidance regarding which subjects
to select for genotyping (Table 2). When using genotypes
from only a selected pair of affected subjects, GIGI was
unable to impute the causal mutation in other subjects
with high confidence, and after imputing genotypes,
there was no evidence of association between the causal
variant and the disease (c2 ¼ 2.06; p ¼ 0.152). Because
the causal mutation is rare, the two selected subjects
both had heterozygous genotypes, so their genotypesect the Performance of Genotype Imputation
SNPs
Rank Accuracy (%) Percentile (%) Rank
1 81.9 100 1
2 80.4 99.5 2
6 75.1 0.5 6
4 77.4 29.0 4
5 77.3 27.5 5
3 79.1 84.5 3
S4 for actual subjects selected.
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Figure 6. Correlation between Imputa-
tion Performance and Estimated
Coverage for Seven Subjects Selected
Per-data-set accuracy (A) and sensitivity (B)
versus local coverage computed for data
set 1 and average accuracy (C) and sensi-
tivity (D) versus genome-wide coverage
computed across ten data sets.could not be phased. After adding the three subjects sug-
gested by GIGI-Pick, GIGI was able to impute the presence
of the causal mutation in 22 other subjects. Among the 12
confirmed subjects who had known copies of the causal
mutation, GIGI was able to impute copies of the causal
mutation in 11 subjects. For the single subject in which
the causal mutation was not imputed with high confi-
dence (the ‘‘missed’’ subject), the estimated probability
that the genotype contained the causal mutation was still
63%. Moreover, GIGI-Pick imputed copies of the causal
mutation in 13 subjects who were originally not typed
and thus could not be confirmed. Among these subjects,
ten were affected, so these subjects were highly likely to
indeed have copies of the causal mutation. Using these
imputed genotypes, we observed strong evidence that
this causal mutation is associated with the disease (c2 ¼
16.85; p ¼ 4.05 3 105). Even though this analysis started
with only five observed subjects, the results match closely
with what could be obtained from the use of all 39 origi-
nally observed subjects for imputing additional genotypes
and then performing the same association test (c2¼ 18.19;
p ¼ 2.00 3 105).
Analysis of other initial pairs of affected subjects gave
similar results. In any pairs of affected subjects, GIGI also
could not impute causal mutations in the relatives, most
often because genotypes at the causal locus in both of
these subjects were heterozygous. In each of these pairs,
the addition of three subjects suggested by GIGI-Pick
enabled imputation of copies of the causal mutation: the
same 25 copies of the causal mutation were always called.264 The American Journal of Human Genetics 94, 257–267, February 6, 2014In the pairs that contained the
‘‘missed’’ subject as one of the five
sequenced subjects, GIGI called an
extra copy of the causal mutation
because the causal mutation from
the ‘‘missed’’ subject was then directly
genotyped. We note that in our
primary analysis with a MAF of 0.2,
GIGI could not impute the causal
mutation into other subjects unless
additional subjects were added, but
with a lowMAF of 0.01, GIGI imputed
the causal mutation even with only
two affected subjects in 17 out of 23
pairs of subjects. This is because of
the strong prior information provided
by the low frequency. However, in
most cases, such allele frequency in-formation would not be initially available, or for more
complex traits, the causal allele(s) might not be so rare.Discussion
The framework that we describe here effectively guides
subject selection for sequencing in pedigrees. The results
from our simulations show that relative to other methods
considered, GIGI-Pick yields superior genotype imputation
performance, especially for rare alleles. Comparisons
between GIGI-Pick (local) and GIGI-Pick (GW) also show
that leveraging inferred IVs further improves genotype
imputation within a focused region with prior evidence
of linkage. In addition, high local and genome-wide esti-
mated coverages are indicative of high subsequent geno-
type-imputation performance, so the use of estimated
coverage is a beneficial metric for determining final selec-
tion choices. Using a real pedigree with a knownmutation,
we also demonstrated that GIGI-Pick can flexibly accom-
modate preselected subjects who are affected by the disease
to suggest additional subjects to sequence; thus, it can lead
to accurate and extensive imputation of the causal muta-
tion and demonstrates the value of such imputed data in
association testing.
Our results also provide valuable insight into how
various subject-selection programs perform with regard
to subsequent genotype imputation. At one extreme,
PRIMUS selected mostly founders. At the other extreme,
ExomePicks selected groups of closely related subjects







Calleda c2 (p value)b
2c 63 2 2.06 (0.152)
5c,d 60 25 16.85 (4.05 3 105)
39 26 26 18.19 (2.00 3 105)
aEither observed or imputed with high-confidence threshold by GIGI with t1 ¼
0.9 and t2 ¼ 0.95.
bComputed at the causal variant.
cAll choices of the initial chosen pair of affected subjects gave the same numer-
ical values.
dUsing the two preselected affected subjects, we used GIGI-Pick to suggest
three more subjects for sequencing, giving a total of five subjects.from the top to the bottom generations of the pedigree.
GIGI-Pick fell between these extremes and balanced
between selecting closely related subjects to increase the
chance of phasing genotypes and selecting distantly
related subjects to increase the number of copies of inde-
pendent founder chromosomes. The results from our study
illustrate that such an approach can substantially improve
imputation performance. Along with the use of inferred
IVs to target selection for a specific region, GIGI-Pick en-
ables efficient selection of subjects for genotype imputa-
tion.
The coverage metric accounts for phasing genotypes
relative to IVs and focuses on using information from IVs
to impute genotypes. When genotypes are imputed with
IVs, the accuracy is well controlled,18 so maximizing
coverage essentially maximizes the average percentage of
alleles that can be called. The estimation of local and
genome-wide coverage extends the theoretical measure
of coverage to two realistic situations: where linkage infor-
mation is and is not already available. Even though
coverage is not specifically designed for imputing rare
alleles, our results from simulated and real pedigrees
demonstrate that this metric works well in practice.
Finally, we anticipate that the use of imputed results
from subject-selection choices based on maximizing
coverage will improve the power of association tests of
rare variants segregating in individual pedigrees over the
use of imputed results from less ideal selection choices
because the validity of the association test ultimately de-
pends on high sensitivity and specificity of calling such
rare alleles.
Variant prioritization based on linkage evidence and
subsequent causal-variant search using imputed genotypes
are together an effective approach to screening sequence
variation. Because linkage information is derived from
the transmission of alleles in pedigrees, it offers strong
prior information to narrow the search space of causal
variants.5,7,14 We have shown here that making use of
this information in selecting sequencing subjects is both
possible and also useful. In a focused region, the use of
statistical tests with imputed genotypes can formally quan-The Americtify scientific evidence, and the use of imputed genotypes
canmarkedly improve the power of statistical testing while
negligibly increasing cost19,20 (and unpublished data). In
addition, because the use of arbitrary bioinformatics filters
is not always regarded as safe,7,15 performing statistical
tests on sequenced variants might be needed prior to
more expensive direct genotyping of variants. This might
be the case especially in studies that involve complex
diseases with reduced penetrance and genetic heterogene-
ity and in which the use of bioinformatics filters is less
effective.42 Recently, the use of a comprehensive evalua-
tion of imputed genotypes along with statistical tests has
been shown to be an effective strategy for nominating
causal variants from sequence data in a study of a complex
trait (triglyceride levels) in a large human pedigree43 and
in a study of an outbred rat cross to identify causal muta-
tions in multiple phenotypes.44 GIGI-Pick can facilitate
such an approach by optimizing the selection of subjects.
Of course, other options, including direct genotyping,
can also be used for following up on the sequencing
results. More generally, prioritizing variants for sequencing
studies and subsequent analyses is important in both
GWASs and pedigree-based studies. Other aspects perti-
nent to the design of the studies are worth considering
but are beyond the scope of the current paper.21
In addition to the incorporation of existing genotypes,
the incorporation of phenotype information could be
beneficial if it is available. In our example with real anal-
ysis, we leveraged phenotype information by first selecting
two affected subjects. Alternatively, potential extensions to
our framework could allow phenotype information to be
leveraged explicitly, both in cases when IVs are available
and in cases when only the pedigree structure is available.
With inferred IVs, further incorporation of phenotypes
might provide additional information to inform which
affected subjects with rare alleles should be sequenced,
and this could be particularly useful when the inferred
IVs are not perfectly informative regarding the transmis-
sion of chromosomes in pedigrees. This future direction
would be interesting to pursue, given that in a large popu-
lation with many related subjects, leveraging phenotype
information with kinship coefficients even without
leveraging inferred IVs to select subjects suggests the
potential to improve power to detect association (M.
Wang et. al, 2013, IGES, abstract). Future investigation
would enable us to understand the power to incorporate
phenotype information to our flexible framework.
We have introduced a quantitative framework to address
the issue of subject selection for sequencing in pedigrees.
The metric used here for evaluating selection choices
relates to genotype imputation. However, other metrics
are also possible and could be developed for the incorpora-
tion of intended analyses and other sources of informa-
tion, including trait phenotypes. Future work will be
needed for evaluating other such options. With this frame-
work, we have implemented the computer program GIGI-
Pick to facilitate efficient and informed decision of subjectan Journal of Human Genetics 94, 257–267, February 6, 2014 265
selection for sequencing; this will be immediately useful in
view of the large number of sequencing projects now being
carried out in existing pedigree samples.Supplemental Data
Supplemental Data include five figures and four tables and can be
found with this article online at http://www.cell.com/AJHG.Acknowledgments
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